Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01877876 · ClinicalTrials.gov registry record

Assessing the Accuracy of the RevK Sensor

A clinical trial, sponsored by University of California, San Francisco.

Completed
Registry status
8
Enrollment target

NCT01877876: Completed study, sponsored by University of California, San Francisco.

NCT01877876 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01877876 has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
8 participants
Enrollment target

Study Summary

Evaluation of a new generation of sensors for monitoring blood hemoglobin. The newest version is RevK.

Primary Outcome

Primary outcome is based on the difference between a value from the SpHb (Masimo SpHb™ continuous hemoglobin reading) minus tHb (laboratory hemoglobin determination).

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2013-06
Est. Completion 2015-06

What the finished NCT01877876 record still lists

NCT01877876 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01877876 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01877876 about?

NCT01877876 is a clinical study titled "Assessing the Accuracy of the RevK Sensor". Evaluation of a new generation of sensors for monitoring blood hemoglobin. The newest version is RevK.

What is the current status of trial NCT01877876?

This trial is currently completed. The enrollment target is 8 participants. The study started on 2013-06. Estimated completion is 2015-06.

Who is sponsoring clinical trial NCT01877876?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01877876, the US trial registry maintained by the National Library of Medicine. NCT01877876 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.